SIMIONI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.836
AS - Asia 4.440
EU - Europa 3.971
SA - Sud America 110
AF - Africa 52
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 19
Totale 36.451
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.789
SG - Singapore 2.293
CN - Cina 1.453
IT - Italia 1.036
FI - Finlandia 671
DE - Germania 662
SE - Svezia 385
VN - Vietnam 330
FR - Francia 277
GB - Regno Unito 247
HK - Hong Kong 235
UA - Ucraina 218
RU - Federazione Russa 214
BR - Brasile 85
NL - Olanda 77
IN - India 62
IE - Irlanda 47
AT - Austria 37
CA - Canada 34
CI - Costa d'Avorio 34
AU - Australia 16
EU - Europa 15
CH - Svizzera 13
RO - Romania 13
AR - Argentina 12
BE - Belgio 11
ES - Italia 11
BG - Bulgaria 9
JP - Giappone 9
TR - Turchia 9
EG - Egitto 8
CZ - Repubblica Ceca 7
NZ - Nuova Zelanda 7
PH - Filippine 6
GR - Grecia 5
MX - Messico 5
TW - Taiwan 5
VE - Venezuela 5
AL - Albania 4
CL - Cile 4
DK - Danimarca 4
IL - Israele 4
IQ - Iraq 4
NO - Norvegia 4
PL - Polonia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
LT - Lituania 3
NP - Nepal 3
RS - Serbia 3
BD - Bangladesh 2
CY - Cipro 2
ID - Indonesia 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LY - Libia 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BS - Bahamas 1
EE - Estonia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
SZ - Regno dello Swaziland 1
TH - Thailandia 1
TN - Tunisia 1
UG - Uganda 1
Totale 36.451
Salva come PNG Salva come JPEG
Città #
Fairfield 4.626
Woodbridge 2.971
Houston 2.065
Ann Arbor 1.994
Ashburn 1.985
Chandler 1.929
Seattle 1.653
Wilmington 1.528
Cambridge 1.499
Singapore 1.117
Jacksonville 953
Boardman 714
Princeton 600
Santa Clara 541
San Diego 486
Beijing 384
Medford 334
Des Moines 324
Helsinki 324
Dong Ket 322
Roxbury 250
Padova 239
Hong Kong 228
Nanjing 219
Villafranca Padovana 170
Munich 105
Hebei 81
Shenyang 81
Nanchang 78
London 71
Milan 63
Nuremberg 60
Norwalk 53
New York 49
Jiaxing 47
Jinan 43
Los Angeles 43
Dublin 41
Tianjin 41
Redwood City 36
Abidjan 34
Guangzhou 34
Ogden 33
Changsha 32
Falls Church 31
Kilburn 25
Bologna 24
Shanghai 23
Chicago 22
Kharkiv 20
Zhengzhou 20
Falkenstein 19
Rome 19
Lappeenranta 17
Pune 17
Amsterdam 15
Dallas 15
Washington 15
Hangzhou 14
Indiana 14
Nürnberg 14
Turin 14
Verona 14
Borås 13
Vienna 13
Chiswick 12
Rockville 12
Frankfurt am Main 11
Hefei 11
Sydney 11
Dearborn 10
Mykolayiv 9
Ningbo 9
Portsmouth 9
Brussels 8
Council Bluffs 8
Ferentino 8
Kunming 8
Las Vegas 8
Acton 7
Kingston 7
Legnaro 7
Redmond 7
Sofia 7
Taiyuan 7
Taizhou 7
Tappahannock 7
Treviso 7
Florence 6
Genoa 6
Haikou 6
Lanzhou 6
Prescot 6
Southwark 6
Toronto 6
Venice 6
Altavilla Vicentina 5
Belluno 5
Esslingen am Neckar 5
Jyväskylä 5
Totale 29.123
Salva come PNG Salva come JPEG
Nome #
Whole blood thromboelastometry profiles in women with preeclampsia 243
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 204
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 200
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 186
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 178
Dynamics of circulating microparticles in obesity after weight loss 158
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 152
Activated protein C resistance in normal and pre-eclamptic pregnancies 145
In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context 145
Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma - Characterization of the dysfunctional protein C Padua(3) (Protein CR-1L/propeptide) 144
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings. 143
Are thromboelastometric and thromboelastographic parameters associated with mortality in septic patients? A systematic review and meta-analysis 142
Secondary parenchymal and vascular changes after middle cerebral artery stroke in children. 139
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 139
Acute oppressive chest pain in a 66-year-old woman with a recent Amplatzer device closure of patent foramen ovale 137
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 137
Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. 133
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 131
The Coagulative Profile of Cyanotic Children Undergoing Cardiac Surgery: The Role of Whole Blood Preoperative Thromboelastometry on Postoperative Transfusion Requirement 129
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 129
A matrix-assisted laser desorption/ionization time-of-flight based method for screening the 1691G --> A mutation in the factor V gene 128
Clinical Data of Neonatal Systemic Thrombosis 126
Microparticles as biomarkers of venous thromboembolic events 125
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 124
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 124
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 123
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 122
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 122
null 122
Cerebral sinus venous thrombosis with parenchymal infarcts in a newborn with severe haemophilia A and subdural haematomas. 122
ABO blood group and the risk of post-thrombotic syndrome 122
Platelet factor V levels in moderate to severe congenital factor V deficiency. 121
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 121
Cerebral sinovenous thrombosis in children: thrombophilia and clinical outcome. 120
Predictors of postoperative bleeding in children undergoing cardiopulmonary bypass: A preliminary Italian study 119
Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease 119
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 119
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 117
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 116
Short-term exposure to high levels of air pollution as a risk factor for acute isolated pulmonary embolism. 115
Cell therapy for Parkinson's disease: A translational approach to assess the role of local and systemic immunosuppression 114
Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery 114
COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward 114
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. 113
Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation 113
Studies on coagulation incompatibilities for xenotransplantation. 112
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 112
Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients 112
Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study 112
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 112
Effects of glycosaminoglycans and protamine chloridrate on platelet aggregation induced by collagen and thrombin. 111
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 111
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies 111
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis. 110
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 110
The biological inertia of coumarin-induced pre-factors (so called PIVKAs) 109
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 109
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein i antibodies. A comparison with a homemade ELISA method 108
Clinical and laboratory characteristics of isolated lupus anticoagulants 108
The molecular genetics of familial venous thrombosis 108
Effects of long-term administration of recombinant human protein C in xenografted primates. 108
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 107
Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation 107
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: A role for circulating microparticles? 107
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 107
The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. 106
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. 106
Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families. 106
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 106
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 106
Procoagulant activity in children with community acquired pneumonia, pleural effusion and empyema 105
Cerebral sinovenous thrombosis in children: Thrombophilia and clinical outcome. 105
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 105
Patient blood management in cardiac surgery: The “Granducato algorithm” 105
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference 105
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience 105
The Risk of Cancer Progression in Women With Gynecological Malignancies and Thrombophilic Polymorphisms: A Pilot Case-Control Study. 104
Thrombotic manifestations in plasminogen deficiency and in plasminogen abnormalities. 104
Predictors of Response To Anticoagulant Therapy For the Treatment of Portal Vein Thrombosis (pvt) In Cirrhosis Patients 104
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 104
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency 103
More severe hypercoagulable state in acute COVID-19 pneumonia as compared to other pneumonia 103
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants 102
Factor VIIa-antithrombin complexes in children with ischemic stroke. 102
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 102
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 102
On-treatment platelet reactivity in peripheral and coronary blood in patients undergoing primary PCI for ST-segment elevation myocardial infarction (STEMI) 102
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 102
Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. 101
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. 101
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 101
Heterozygous protein-S deficiency: a study of a large kindred. 101
Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area 100
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 100
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 100
Hypercoagulability In Cirrhotic Patients With Hepatocellular Carcinoma (hcc) and Portal Vein Thrombosis (pvt) 100
Naturally occurring Arg-1 to Leu mutation in human protein C (protein C Padua(3)) resulting in an abnormal propeptide processing and in a molecule with discrepant functional activities 100
Pitfalls of protein C assays in patients with activated protein C resistance 99
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 99
Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg. 99
Totale 11.895
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.414
article - articoli 144.110
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 174
Totale 291.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.164 0 0 0 0 0 0 0 0 846 675 317 326
2020/20215.413 181 424 254 503 522 255 171 521 609 626 589 758
2021/20225.842 181 604 694 402 310 381 249 668 319 155 535 1.344
2022/20234.087 892 389 93 427 716 505 16 279 477 48 188 57
2023/20242.349 105 337 255 222 168 238 163 106 93 99 244 319
2024/20256.063 34 829 518 378 1.352 310 577 891 1.174 0 0 0
Totale 36.933